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Abstract
Background: Patients following prolonged cancer chemotherapy are at high risk of emotional and cognitive
deficits. Research indicates that the brain neuronal temporal coding and synaptic long-term potentiation (LTP)
are critical in memory and perception. We studied the effects of cisplatin on induction of LTP in the basolateral
amygdala (BLA)-anterior cingulate cortex (ACC) pathway, characterized the coordination of spike timing with local
theta oscillation, and identified synchrony in the BLA-ACC network integrity.
Results: In the study presented, the impacts of cisplatin on emotional and cognitive functions were investigated by
elevated plus-maze test, Morris water maze test, and rat Iowa gambling task (RGT). Electrophysiological recordings
were conducted to study long-term potentiation. Simultaneous recordings from multi-electrodes were performed
to characterize the neural spike firing and ongoing theta oscillation of local field potential (LFP), and to clarify the
synchronization of large scale of theta oscillation in the BLA-ACC pathway. Cisplatin-treated rats demonstrated
anxiety- like behavior, exhibited impaired spatial reference memory. RGT showed decrease of the percentage of
good decision-makers, and increase in the percentage of maladaptive behavior (delay-good decision-makers plus
poor decision-makers). Cisplatin suppressed the LTP, and disrupted the phase-locking of ACC single neural firings
to the ongoing theta oscillation; further, cisplatin interrupted the synchrony in the BLA-ACC pathway.
Conclusions: We provide the first direct evidence that the cisplatin interrupts theta-frequency phase-locking of
ACC neurons. The block of LTP and disruption of synchronized theta oscillations in the BLA-ACC pathway are
associated with emotional and cognitive deficits in rats, following cancer chemotherapy.
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Introduction
The ‘chemobrain’ refers to a range of cognitive deficits
caused by prolonged chemotherapy. In clinical studies,
depression and cognitive impairment were found in 40
to 70 % of patients following cancer therapy [1]. Cis-
platin, a platinum compound, is an anticancer drug
widely used for the chemotherapy of different malignan-
cies. It has been shown in non-human primates that cis-
platin can penetrate the Blood Brain Barrier (BBB) and
accumulate in the cerebrospinal fluid of the brain [2],
affect several neurobiological processes [3, 4] including
oxidative stress [5]. At the cellular level, chemothera-
peutic agents target the central nervous system (CNS)
proliferating cells as well as changing fate decisions and
cellular functions of neural progenitor cells [3]. Consid-
ering that these agents are potent neurotoxins [6], they
may contribute to neurobiopathlogical processes, such
as apoptosis and cell death correlated with platinum-
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DNA binding [6, 7], which are involved in the progress of
cognitive deficiency following chemotherapy [8]. At the
synaptic level, activity-dependent plasticity in synaptic
strength, such as long-term potentiation (LTP), is a key
mechanism in shaping cortical circuits [9, 10]. Therefore,
the study of the effect of cisplatin treatment on the modula-
tion of synaptic transmission in animal model may explain
its influence on cognitive function.
The anterior cingulated cortex (ACC) is a major cor-
tical area of the limbic loop system, integrating emotion
and cognition. The anatomic connections between the
ACC and the amygdala have been clearly reported pre-
viously [11, 12]. Indeed, an indirect linkage in the ACC-
thalamus-amygdala circuitry [13, 14] plays an important
role in synchronized function between the thalamus and
amygdala, and ACC [15]. However, the synaptic meta-
plasticity in the amygdala-ACC circuitry following pro-
longed chemotherapy has not been fully explored.
Therefore, we sought to characterize if chemotherapy
disrupts LTP in the amygdala-ACC network integrity,
which is associated with mood disorder and deficits of
learning and memory.
Coordinated action-potential timing across popula-
tions of neurons is necessary for induction of synaptic
plasticity [16]. Recent neurobiological studies of human
memory and perception share common observations of
theta frequency band oscillations in the brain and
coherency of the theta oscillations and action potential
activity. Rutishauser et al. have shown that memory
formation in humans is predicted by close coordination
of spike timing with the local theta oscillation [17]. This
suggests that synchronized oscillatory activity promotes
the communication between anatomically distant, yet
functionally related, structures during learning.
In previous animal research chemotherapy-related
mood and cognitive deficits have not been investigated
systematically [8]. Our goal in the present study was to
go beyond previous animal work, by characterizing the
alteration of phase-locking of neural activity to the theta
oscillation. And as such allowing identification of the
disruption of the amygdala-ACC network synchrony
associated with impairment of cognition and behavior
after chemotherapy. In order to accomplish this we per-
formed a series of behavioral assessments in rats follow-
ing chronic administration of cisplatin, in particular the
rat Iowa gambling task (RGT) was used to assess decision
making functions in rats [18]. To characterize synaptic
plasticity in vivo, we recorded evoked local field potentials
(LFP) and induced LTP in the basolateral amygdala
(BLA)-ACC pathways. Simultaneous recording from an
array of microelectrodes allows characterization of the dis-
ruption to the phase-locking of single neural spike firing
with the ongoing theta oscillation of LFP in a large scale
population of neurons in the ACC and identifying the
desynchronized theta activity between BLA and ACC
following administration of cisplatin.
Results
Cisplatin suppressed spontaneous exploratory activity
To examine if cisplatin-treated rats develop anxiety-like
behavior we performed open field test (OFT). The OFT is
often used to assess exploration in a novel environment
and offer a preliminary screen for anxiety-related behavior
in rats [19].
Cisplatin-treated rats exhibited a lower total horizontal
distance traveled (horizontal activity; t = 2.54, p < 0.05), a
reduced number of rearings (vertical activity; t = 4.08, p <
0.001), a reduced time spent in (t = 3.01, p < 0.01) and num-
ber of entries into the center (t = 3.29, p < 0.01) during the
5-min testing session (Fig. 1a, b, c, d). In contrast to the
controls, rats with cisplatin treatment exhibited strongly
increased freezing behavior (t = 4.21, p < 0.001; Fig. 1h).
Anxiety-like behavior
To confirm the anxiety-like behavior we performed elevated
plus-maze (EPM) test. The EPM is a popular behavioral test
for anxiety-like behavior and is thought to result from nat-
ural aversion of rats to explore elevated and open areas [20].
The EPM tests showed that cisplatin-treated rats
exhibited a reduced time in the open arms (t = 3.07, p <
0.01; Fig. 1e) and a lower percentage of time spent in
the open arms versus closed arms (t = 2.79, p < 0.01;
Fig. 1f ) when compared with control rats, suggesting
increased anxiety-like behavior induced by chronic cis-
platin treatment. As previously observed in the open
field test (OFT), rats with cisplatin also exhibited a
higher level of freezing behavior during exposure to the
elevated plus-maze (EPM) (t = 2.71, p < 0.05; Fig. 1g).
Spatial reference recent and remote memory
To investigate the learning acquisition processes and
memory ability we conducted Morris water maze task
[21]. The test used was described by Kesner [22] as a
test of prefrontal cortex (PFC) function. Its goal is to as-
sess the ability of rats to learn the position of the hidden
platform and to keep this information online during
four consecutive trials.
Swimming speed did not change in cisplatin-treated
rats during probe training (acquisition trials) in Morris
water maze (MWM). Escape latencies were used to indi-
cate the ability to learn the location of a submerged
platform using visual cues. There was a significant effect
on escape latencies for groups (F (1,31) = 8.03 and F
(1,24) = 8.87; both p < 0.01 for recent and remote mem-
ory), for trials (F (3,31) = 35.35 and F (3,24) = 41.59; both
p < 0.001) for recent and remote memory), and for their
interaction (F (3,93) = 3.80 and F (3, 72) = 2.85; both
p < 0.05 for recent and remote memory). These results
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suggest that cisplatin-treated rats spent more time
trying to find the platform during 4-day acquisition over
the course of several trials (Fig. 2a and b). Spatial mem-
ory was assessed in a single 60 s probe test in which rats
searched the target quadrant that previously contained the
escape platform. Control animals showed a significantly
higher percentage of time spent in the target quadrant
compared with cisplatin rats when tested in a probe trial
24-h after training (t = 3.33, p < 0.01; Fig. 2c) and in 30-
day after training (t = 3.61, p < 0.01; Fig. 2d), suggesting
Fig. 2 Spatial reference learning and memory impairment observed in cisplatin-treated rats exposed to the water maze test. a - b In the probe
training sessions, the acquisition curve of cisplatin rats was impaired compared with control rats. c - d In 60 s probe tests, cisplatin-treated rats
spent significantly lower percentage of time in the quadrant previously containing the platform than control rats, suggesting impaired memory.
An asterisk indicates levels of significance for the difference between controls and cisplatin-treated rats.* p < 0.05, ** p < 0.01
Fig. 1 Anxiety-like behavior in cisplatin treated rats as determined in the OFT and the EPM. a Total horizontal distance traveled, (b) the number of rearings,
(c) the time of spent in the center, (d) the number of entries into the center, and (h) freezing time in an OFT, (e) time spent in open arms, (f) percentage
of time spent into open arms versus closed arms and (g) freezing time for the EPM. Values are given as means + SEM. n = 17 for controls and n= 19 for
cisplatin-treated rats. An asterisk indicates levels of significance for the difference between controls and cisplatin-treated rats. * p < 0.05.
** p < 0.01, *** p < 0.001 vs. control rats
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cisplatin-disrupted memory retrieval in both the recent
and remote memory retention.
Cisplatin-induced behavioral changes in decision-making
during the rat Iowa gambling task
The rat gambling task (RGT) has been developed to test
the decision-making capacities in rats via a conflict
between immediate and long-term gratification (food
reward) [23].
During the RGT different subgroups of decision-making
performers were identified in both the control and
cisplatin-treated rats, based on the percentage of advanta-
geous choices (choice C and D) made during the testing
session (Fig. 3a and b). During the first 10 min of the
60 min testing session, no obvious choice preference was
observed in any subgroup in either the control or cisplatin
group (Fig. 3a and b). Over time, some rats gradually pre-
ferred advantageous choices and finally developed good
decision-making behavior (defined by advantageous
choices >70 % in the last 20 min). Delayed good decision
making behavior was identified when the percentage of
advantageous choices in good decision-makers was
below 70 % at 30 min. Poor decision-making corre-
sponded to those with less than 30 % advantageous
choices in the last 20 min. The remaining rats showed
no obvious preference for either advantageous or disad-
vantageous choices throughout the test (between 30 %
and 70 % preference for advantageous choices in the last
20 min), and were classified as undecided. The propor-
tion of delayed-good decision-makers increased after
repeated cisplatin treatments (8 out of 35 cisplatin rats,
23 %) compared to the control group (2 out of 24
control rats, 8 %), and the proportion of normal good
decision makers was reduced, to 20 % in cisplatin rats
compared to 55 % in controls (Fig. 3c and Table 1). The
proportion of undecided performers in the cisplatin
group was similar to that observed in controls (23 % vs.
20 %, cisplatin vs. control), with 34 % and 17 % poor
decision-makers observed in the cisplatin and control
groups respectively (Fig. 3c and Table 1). The difference
in the proportions of the four subgroups between the
control and cisplatin groups was significant (non-para-
metric Mann–Whitney test, z = −2.27, p < 0.05, Fig. 3c),
suggesting that cisplatin treatment affects decision-
making ability in rats
Impaired LTP-like synaptic plasticity
In all rats, a range of stimuli (50 to 1000 μA) to the BLA
elicited gradually increased ACC evoked LFP (Fig. 4a).
No significant difference was observed between control
and cisplatin rats I/O curves (F = 0.33, p > 0.05, Fig. 4b).
In control rats (n = 5), after three trains of TBS delivered
to the BLA, a 158.4 ± 9.6 % enhancement in LFP ampli-
tude in response to BLA stimuli (500 μA) was observed
compared to the baseline level (pre-TBS). In contrast,
TBS failed to induce LTP in cisplatin-treated rats (n = 6).
Representative evoked LFP are shown in Fig. 4c; there
was no obvious alteration of LFP tested in pre-TBS and
post-TBS condition at any time points in cisplatin rats
(103.7 ± 6.4 %, Fig. 4d). These results indicate that TBS-
induced LTP in the BLA-ACC synapses was impaired
after cisplatin administration. We also detected impair-
ment of LTP induction in large-scale ACC in the
multiple-channel electrode study (data not shown).
Fig. 3 Changes in decision-making behavior induced by cisplatin using a rat Iowa gambling task. a – b Time course of percentage of advantageous choices
for good (white), delayed good (grid), undecided (30 % gray) and poor (black) decision-makers during a 60 min RGT testing in control (A circles) and cisplatin
(B squares) rats. Within the first 10 min, rats chose equally between advantageous and disadvantageous choices. They then quickly developed four distinct
subgroups based on the percentage of advantageous choices during the 60 min test (>70 % preference of advantageous choices at 30 min and in the
last 20 min for good decision-maker, < 70 % preference of advantageous choices at 30 min and> 70 % preference in the last 20 min for delayed good
decision-maker, < 30 % in the last 20 min for poor decision-maker, and 30 - 70 % in the last 20 min for undecided maker). c Proportions of good performers
(white bar), delayed good performers (grid bar), undecided behavior (30 % gray bar) and poor decision-making (black bar) for control group and cisplatin
group. Advantageous choices (%) = numbers of nose-poke for choices (C +D) / numbers of nose-poke for choices (A + B +C+D) * 100 %. n = 24 for control
group, n = 35 for cisplatin group
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Enhanced ACC theta activities
To characterize the theta rhythm activity of the ACC,
power spectral analysis was performed during 30 s spon-
taneous and 30 s CRD stimulation in two groups of rats.
The AUC of the theta band power are shown in Fig. 5b
(n = 7 for control and 7 for cisplatin group), a significant
alteration between the groups was detected (F = 7.71; p
< 0.001). Post hoc analysis revealed that the ACC theta
power during both spontaneous activity (t = 3.32; p <
0.05) and visceral pain condition (60 mmHg CRD; t =
3.28; p < 0.05) were enhanced in cisplatin rats compared
with control. In control rats the ACC theta power was
3.58 ± 0.64 and 4.17 ± 0.55 × 10−4 mV2, while in cisplatin
rats the ACC theta power were 6.10 ± 0.37 and 6.84 ±
0.60 × 10−4 mV2 in spontaneous conditions and during
CRD stimulation respectively. Theta/delta ratios were
also evaluated (Fig. 5d); post hoc analysis revealed that in
cisplatin-treated rats under spontaneous conditions, ACC
theta/delta ratio was enhanced from 8.50 ± 0.80 to 13.77
± 1.08 % (t = 2.91; p < 0.05). And during CRD stimulation,
the theta/delta ratio was increased from 12.85 ± 1.44 to
19.94 ± 1.60 % (t = 4.08; p < 0.05). These data indicate that
cisplatin enhances ACC theta activities.
Disrupted spikes phase-locking to theta oscillation in the
ACC in cisplatin-treated rats
To further investigate the strength of coupling between
spike timing and LFP at any given frequency, we next asked
whether spike phase distributions in the local theta oscilla-
tion of local field potential were changed in rats after cis-
platin treatment. As expected, we found that in control rats
44.2 % of neurons (53 of 120 neurons) fired spikes that
were phase-locked to the LFP oscillations in theta range
(Fig. 6a, p < 0.0023, 0.05/22, Rayleigh’s test). The preferred
Table 1 Number and percentage of individuals exhibiting the behavior observed during the RGT for both the control and cisplatin
groups
Number of individuals Control group (n = 24) Cisplatin group (n = 35)
n (%) n (%)
Good decision makers 13 (55 %) 7 (20 %)
Delayed-good decision-makers 2 (8 %) 8 (23 %)
Poor decision-makers 4 (17 %) 12 (34 %)
Undecided decision-makers 5 (20 %) 8 (23 %)
Fig. 4 Long-term potentiation (LTP)-like plasticity in the basolateral amygdala (BLA)-ACC synapse was impaired in cisplatin-treated rats. a Representative ACC
evoked local field potential (LFP) responses to different-intensity BLA stimuli (200, 400 and 800 μA) in both control and cisplatin rats. b Averaged input/output
(I/O) curves of BLA-ACC evoked LFP showed no significant alteration between control and cisplatin-treated rats. c Examples of LFP responses in the ACC to
BLA stimuli before (pre-) and 40 min after (post-) theta burst stimulation (TBS) in control and cisplatin-treated rats. d LTP was reliably induced in control rats
(n = 5). But in cisplatin-treated rats, the LTP induction was impaired when tested with a stimulate intensity that evoked about 50 % of the maximum LFP
amplitude (n = 6). Results are expressed as mean± SEM
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frequency of phase-locked neurons was 8.03 ± 0.98 Hz.
In contrast, in cisplatin group, only 12.8 % (19 of 149
neurons) showed phase-locking at theta range. In con-
trol rats the neurons had a range of phase preferences,
with the majority (27 of 53 neurons, 51 %) firing close
to the trough of the theta band oscillation (±45° around
trough; Fig. 6b). Examples of phase distributions of a
phase-locked neuron in a control rat and an un-phase-
locked neuron in a cisplatin rat are presented as polar-
histograms (Fig. 6c and d). The phase-locked neuron in
the control rat showed most spikes firing at between
120° and 240° of the theta cycle with a mean-phase of
184°. However, in cisplatin-treated rat the un-phase-
locked neuron displayed random firing. Together, the
results indicate the disruption of the ACC phase distri-
bution of single neuron spikes in relation to ongoing
local field potential in cisplatin rats.
Desynchronized theta activities in BLA and ACC
To examine the synchronous activities between BLA
and ACC we compared theta oscillations of the local
field potential at rest and during noxious stimulation in
both the control and cisplatin-treated rats. Here, the
CRD-induced responses provide an index of how the
system responds to activation. The original traces of
spontaneous theta activity are shown in Fig. 7a. Time-
varying power spectral analysis of 120 s recordings
revealed that the concentrated neuronal activities in the
ACC and BLA of control rats, both at rest and during
visceral pain stimulation (CRD 30 s), became dispersed
at theta frequencies in cisplatin rats (Fig. 7b). Cross-
correlation analysis allows quantitative evaluation of the
synchronized activity in the LFP. By averaging the
cross-correlograms and taking the second positive peak
as a quantitative measure (Fig. 7c), a significant differ-
ence was detected (F = 21.35, p < 0.001; Fig. 7d). Post
hoc analysis revealed that in spontaneous conditions
(basal) the correlation values were decreased in cisplatin
rats, from 0.147 ± 0.013 in control rats (n = 6) to 0.090
± 0.005 in cisplatin rats (n = 6; t = 3.93, p < 0.05). During
visceral pain stimulation the cross-correlation values of
control rats were increased from 0.147 ± 0.013 at basal
values to 0.174 ± 0.010 during CRD (t = 3.42, p < 0.05).
In contrast, in cisplatin rats visceral pain stimulation
failed to alter the cross-correlation value between BLA
and ACC (0.090 ± 0.010 of basal vs. 0.085 ± 0.005 during
CRD, t = 2.77, p > 0.05). The result suggests desynchro-
nized activity between BLA and ACC in both resting
and visceral pain stimulation in cisplatin-treated rats.
This indicates that the BLA and ACC may only loosely
interact for dynamic information transfer after cisplatin
treatment.
Fig. 5 Enhanced the power of ACC theta-band oscillation (4–10 Hz) in cisplatin-treated rats. a The 16 channels LFP oscillations in the theta band frequencies
recorded from the ACC. b The averaged power spectral density (PSD) showing a wider band of frequencies (0–15 Hz) in control and cisplatin-treated rats
during spontaneous and CRD conditions. The main peaks of the PSD located during 1–4 Hz (delta band), the second peaks as magnified in the inset show
power distributions in the 4–10 Hz (theta band) in different groups. c The average AUC of theta band PSD in control and cisplatin-treated rats showing
increases in theta-band oscillation (4–10 Hz) power during both spontaneous and CRD stimulate conditions in cisplatin rats. d The histogram shows the
enhancement of theta/delta ratio (theta/(theta + delta) in cisplatin rats. Data are expressed as mean± SEM. # p < 0.05 vs. control
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Discussion
Using a model of chemotherapy associated with emotional
and cognitive deficits, this is the first study to investigate
the synaptic plasticity characterized by the phase-locking
of the neural spike firing with the ongoing theta oscillation
of the LFP. We also clarify the synchronization of large
scale theta oscillation in the BLA-ACC pathway. Single cy-
tostatic agent cisplatin was used instead of a chemothera-
peutic cocktail in a clinical setting. Cognitive functions
were examined up to two months post treatment and the
animals were free of cancer and other diseases.
In the EPM [20], we observed that cisplatin-treated rats
decreased the amount of time they spent in the open
arms, and significantly increased their freezing time sug-
gesting the development of anxiety-like behavior. Anxiety
is an instinct for promoting adaptive survival by elusion
of unnecessary danger. However, excessive anxiety is
unfavorable reducing even the behavioral activity that is
necessary for adaptation. The amygdala plays a key role in
the expression of anxiety or fear, and the medial prefrontal
cortex is important for regulating the amygdala-mediated
expression of fear [24].
In the spatial reference memory task, the cisplatin-
treated rats showed impaired learning acquisition processes.
Furthermore, these rats spent less time in the platform
quadrant compared to control rats in both recent and
remote probe test suggesting impaired recent and remote
memory.
The hippocampus plays a critical role in spatial memory
formation [8, 25], however, as these memories mature, they
may become more (or even exclusively) dependent on extra
hippocampus structures. Previous studies demonstrated
that the medial prefrontal cortex (mPFC) specifically the
ACC play a key role in the expression of remote spatial
memories [26, 27]. Employing a conditional place avoid-
ance test we recently showed, that ACC neuronal activities
play a key role in visceral pain aversion memory processing
in awake rats [28]. Using a visceral hypersensitive rat model
we have demonstrated that ACC hypersensitivity can be
observed up to 7 weeks after the initiation of colonic
anaphylaxis and is independent of mucosal inflammation.
The prolonged ACC sensitization enhanced visceral pain
responses by descending facilitate system [29], this suggests
triggering of pain memory in the ACC neuronal circuitry
[30–32]. More recently, electrophysiological recording
showed LTP of local field potential can be reliably induced
in the medial thalamus-ACC synapses by TBS condition
stimulation in normal rats [33]; however, this canonical
LTP induction was occluded in chronic pain state [33].
Interestingly, similar results were observed in the present
studies, the data demonstrate for the first time that cisplatin
effectively blocks the expression of LTP at amygdala-ACC
Fig. 6 Cisplatin disrupted the spikes phase-locking in the ACC. a Test of significance of phase-locking as a function of frequency (1 – 64 Hz). The threshold
(red line) for significant phase-locking was set to p = 0.0023 (0.05/22, Bonferroni corrected). The shown phase-locked neuron in the control rat (gray line)
exhibited maximal phase-locking at 9.5 Hz while the un-phase-locked neuron in the cisplatin-treated rat (black line) showed no significant phase-locking
in theta range. b Histogram of the preferred phase of all phase-locked neurons in the control rats (n = 53 of 120). The figure shows most phase-locked
neurons preferred to fire during the descending phase or at the trough of the oscillation. The red line is a schematic of the theta cycle. c The polar-
histogram of the spike-field phase distribution of the phase-locked neuron from the control rat shown in (A). The figure shows the majority of spikes of
this neuron fired close to 180°. The mean phase shown by the red arrows indicates this neuron preferred firing at 184° of the theta oscillation. The vector
length R = 0.23. d Polar-histogram of the spike-field phase distribution of the un-locked neuron from the cisplatin-treated rat shown in (A). The figure shows
this neurons action potential firing at random angles of the theta cycle oscillations suggesting disrupted phase-locking in rats following cisplatin treatment.
The vector length R = 0.03
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synapses in vivo. This occlusion approach has been com-
monly used to investigate whether the plasticity obtained in
vitro by electrical stimulation is a reliable model for studying
the mechanisms of learning and memory [34]. These results
suggest that chemotherapy agents could causally interrupt
learning and memory [8]. In line with the present results, a
similar LTP occlusion has been found after a fear paradigm
in amygdala [35] and hippocampus [36].
In the brain, there are both small- and large-scale levels
of organization [37]. Neural oscillations play a basic role in
coordinated activity during normal functional brain pro-
cesses [38, 39]. Several lines of evidence suggest that the
theta band (4–10 Hz) in the neural network, which tempor-
ally links single neurons into assemblies, cooperatively facil-
itates synaptic plasticity [40]. Our spectral analysis of ACC
local field activities revealed that on average, the cisplatin-
treated rats exhibited higher spectral power over the
frequency range in theta band (4–10 Hz). However, the
frequency at which theta power reached maximum was not
significantly shifted. It appears that cisplatin affects the
physiological expression of theta oscillation activity, but
does not alter the precise frequency of this oscillation. This
abnormal theta oscillation power is consistent with previ-
ous observations that neurotoxicity of Ecstasy causes an
increase in theta power in EEG which is correlated with a
decline in attention and memory [41]. An animal study
also showed spatial memory deficit accompanied with
hippocampal theta power enhancement caused by neuro-
toxins [42].
A growing body of research evidence suggests that neu-
rons transmit information not only in terms of their firing
rates but also by varying the timing of the spikes corre-
sponding to neuronal oscillations [37]. Induction of LTP is
favorable when higher frequency electrical stimulations were
arrived on the positive phase of theta oscillations [43] Fur-
thermore, behavioral studies in humans and animals have
consistently shown that [9] brain oscillations coordinate
with timing of single-neuron activity [17], synchronously
discharging cells are more effective at driving neurons at
subsequent processing stages [17, 44, 45] than uncoordinat-
edly responding cells. In addition, to advance the under-
standing of the timing relationship between spikes and
ongoing theta oscillation, it is critical to investigate the angu-
lar distributions of spikes with the theta oscillation, and
Fig. 7 Desynchronized theta activities between the BLA and ACC in cisplatin rats. a Representative traces of spontaneous theta band field
potential in the BLA (black line) and ACC (blue line) in control (left) and cisplatin (right) rats. b Time-varying power spectra of BLA (upper) and
ACC (bottom) LFPθs in control and cisplatin rats. c The averaged cross-correlograms of control and cisplatin rats for both spontaneous activity
and during visceral pain stimulation (60 mmHg CRD). d Statistical analysis revealed that the cross-correlation value (the second positive peak)
was decreased in spontaneous theta activity in cisplatin-treated rats compared with control group. Meanwhile, in control rats, CRD significantly
enhanced the correlation value when compared with spontaneous activity. In cisplatin rats there was no changing during CRD stimuli compared
with resting state. Data are expressed as mean ± SEM. *, # p < 0.05
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clarify the significance of phase-locking of spikes in theta os-
cillation [17]. We found that in control rats 44.2 % of ACC
neurons fired spikes that were phase-locked to the LFP
oscillations in the theta range. The preferred frequency of
phase-locked neurons was 8.03 Hz, with maximal activity
during the descending phase and at the trough of the oscilla-
tions. In contrast, only 12.8 % ACC neurons showed phase-
locking at theta range in the cisplatin group. Together, these
results suggest that chemotherapy disrupts phase distribu-
tion of ACC neuron spikes in theta oscillation of LFP.
Decision-making is the result of the integration of several
executive brain areas and has emerged as a crucial theme
in neurophysiological studies of cognition. Animals are in-
dividuals that can exhibit human-like cognitive characteris-
tics, such as the ability to acquire and reason with causal
knowledge [46, 47]. Decision making is complex ; it can be
impaired in psychiatric disorders, such as attention-deficit/
hyperactivity disorder. The Iowa gambling task (IGT) is
frequently used to assess decision-making performance in a
clinical setting [48]. Our RGT results show that good,
delayed-good, undecided, and poor decision-makers could
be identified in the RGT [49]. In the cisplatin-treated group
we observed decreases in the percentage of good decision-
makers, and increases in the percentage of maladaptive be-
havior (delayed-good decision-makers plus poor decision-
makers). Investigators have proved that the ACC plays a
crucial role in selecting proper actions when faced with dif-
ferent benefits in an unsure environment [50] through sig-
naling error-likelihood [51]. The ACC also plays a key role
in choosing appropriate actions when the environment is
dynamic [52, 53] related to the information about the costs
and benefits [54]. It appears that the dysfunction of the
phase-locking of the neural firing with the theta oscillation
may contribute to mediate the decision-making deficits fol-
lowing cancer chemotherapy [49]. In addition, and also in
agreement with other reports [55], our results revealed that
high levels of anxiety were associated with poor decision-
making using the RGT reward model. This is also in line
with human data that highly anxious subjects performed
worse on the IGT [56].
Advantageous decision-making in the gambling task also
requires an intact amygdala [57], which is a key player in
emotions and affective disorders. Accumulating evidence
implicates phase synchronization and large-scale integra-
tion of neuronal activities in different regions as a mechan-
ism linking functionally related regions of the brain [37,
58]. The direct and indirect connections between ACC and
amygdala have been well determined anatomically [11, 13].
Electrical stimulation of the BLA has been shown to change
neuronal firing in the mPFC, with latencies consistent with
monosynaptic and polysynaptic pathways [59]. Behavioral
studies have also shown that the BLA-ACC synaptic path-
way participated in various cognitive functions. For ex-
ample, in chronic pain state, the cognitive impairment was
caused by amygdala-driven prefrontal cortical deactivation
[60]. Synchronous oscillatory activity in the theta band has
been suggested to mediate information flow between
functionally related brain regions during learning and
memory retrieval [61]. Previous studies have shown that
the synchronized activity between frontal and hippocam-
pal regions was modulated by anxiety [62], and enhanced
during the execution of working memory tasks using hu-
man EEG recording [63]. In the current study, we tested
our hypotheses that cisplatin leads to desynchronization
in the amygdala and ACC correlated with deficits in learn-
ing and memory. By simultaneously recording local field
potentials in the ACC and the BLA, cross-correlation and
time-varying power spectral analysis of the theta oscilla-
tions at rest revealed a pattern of dispersion of theta band
activity and reduction in correlation values of cisplatin rats
when compared to the control rats. Furthermore, noxious
stimulation (CRD) enhanced the synchronized theta activ-
ities between BLA and ACC in normal rats but in con-
trast, non-synchronized theta activities were observed
during CRD after cisplatin administration. These data
might be particularly relevant to the failure of introduc-
tion of LTP in the BLA-ACC pathway after administration
of cisplatin. It has been well demonstrated that LTP is in-
duced preferentially on the positive phase of theta oscilla-
tions. In cellular studies it was clearer that whether a
given stimulus triggers synaptic plasticity can depend on
when the stimulus arrives relative to the phase of ongoing
theta oscillation [43]. It appears that higher frequency of
theta burst stimulation (TBS)-induced LTP shared similar
modality with the synchrony of theta oscillation of LFP in
the BLA-ACC pathway. We speculate that the theta
synchronized activity between circuits might promote the
induction of LTP by electrical higher frequency TBS in
these circuits. Together these results provide the first clear
indication that chemotherapy disrupts the phase-locking
of single neural firings with respect to the ongoing theta
oscillation, and further interrupts the synchrony in the
BLA-ACC pathway, which correlates with blocking LTP
induction in this pathway. These observations directly
complement recent seminal findings showing that in hu-
man studies [17], the interruption of neuronal synchrony
appears to impact cognition and behavior.
A limitation of the present study is that electrophysio-
logical studies were performed under anesthesia. We ob-
served an increase in theta/delta ratios after cisplatin
treatment. However, another report showed that temozolo-
mide, another drug for chemotherapy, reduced theta/delta
ratio in hippocampus of conscious rats after 4 weeks of
treatment associated with the disruption of learning [61]. A
series of experiments have shown that theta oscillations are
quite different among anesthetized and different sleep-wake
states in awake rats. Kramis et al. reported two types of
theta rhythm in hippocampus, one is sensitive to astropine
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and the other is abolished selectively during ether or
urethane induced anesthesia [64]. More recently, other
researchers indicated that under anesthesia, hippocampal
activity switched from large-amplitude, irregular activity
to a theta state, and the theta/slow oscillation ratio in-
creased when transiting anesthetized to the waking, which
was mediated by cholinergic [65] and serotonergic neu-
rons [66]. How the neural network between the ACC and
amygdala is coordinately activated in the spatial memory
and RGT reward models in awaken state remains unex-
plored. Future studies are clearly needed, using chronic
implants of arrays of multi-electrodes and recording from
neuronal ensembles during animal behavior. This will en-
able exploration of the neural mechanisms underlying the
functional connectivity between the ACC and amygdala
during events involving learning, memory retrieval, and
decision-making.
In conclusion these results provide the first direct evi-
dence that cancer chemotherapy can reduce the coherence
and interrupt the phase-locking of ACC neuronal spikes
with the ongoing theta band of the LFP. More importantly,
the disruption of the synchronized theta oscillations and
impairment of induction of long-term potentiation of the
BLA-ACC pathway are associated with emotional and
cognitive deficits in rats following cancer chemotherapy.
Materials and methods
Animals
A total of 59 male Sprague–Dawley rats were used in these
experiments; they were housed in standard laboratory con-
ditions (temperature at 23 ± 1 °C and 12/12 h light–dark
cycles with lights on at 7:30 a.m.) The rats were allowed to
adapt to their environments for at least 5–7 days before the
first injection of cisplatin and were handled for 3–5 min
daily for 2–3 days before beginning the behavioral experi-
ments. Rats had free access to water, but had moderate
food deprivation during the decision-making testing. All
surgical and experimental procedures were conducted ac-
cording to the guidelines laid down by the NIH in the US
regarding the care and use of animals for experimental pro-
cedures and were approved by the Committee on Use and
Care of Animals at City University of Hong Kong and the
licensing authority to conduct experiment from Depart-
ment of Health of Hong Kong (No. 13–89 in DH/HA&P/
8/2/5 Pt.2).
Drug treatments
The cisplatin dosage and dosing schedule used in the
present study were based on the clinical usage of cisplatin
treatment into the abdominal cavity in cancer patients,
slightly modified according to previous description in
rodents [4]. Cisplatin (International Laboratory, USA) was
dissolved in 0.9 % NaCl (0.4 mg/ml), warmed to 45 °C and
injected with 1.0 ml/100 g rat. The rats weighing 250–
300 g at the beginning of the experiment received intra-
peritoneal injections of cisplatin or 0.9 % NaCl once every
7–8 days for a total of 6 times in recent memory testing
group and 8 time for remote memory group (Table 2).
Behavioral assessments
Behavioral assessments began after 3 cisplatin administra-
tions. The animals were tested sequentially in a series of
behavioral tests in the following order: (1) open field test
(OFT), (2) elevated plus-maze (EPM), (3) Morris water
maze (MWM), (4) rat Iowa gambling task (RGT). The rats
were given a recovery phase of 5 days before, and 5 days
after MWM to maintain a fair general condition during
chronic cisplatin treatment. All behavioral procedures were
conducted during the light phase of the day. To minimize
possible circadian influences on the rats, cisplatin and
control rats were observed alternate basis.
Table 2 Experimental design
Recent memory Remote memory
Experimental day Treatments Experimental day Treatments
1, 2…13, 14 Drug injections 1, 2…13, 14 Drug injections
15, 16 Habituation 15, 16 Habituation
17 OPT, EPM 17 OPT, EPM
18, 19, 20, 21, 22 Recovery phase before MWM 18, 19, 20, 21, 22 Recovery phase before MWM
23, 24, 25, 26 MWM training 23, 24, 25, 26 MWM training
27 MWM recent testing 27, 28…55, 56 Drug injections
28, 29, 30, 31, 32 Recovery phase after MWM 57 MWM remote testing
33, 34, 35 Food restriction for RGT
36, 37, … 40, 41 RGT training
42, 43 RGT testing and Electrophysiological recording
Cisplatin or saline was administrated on days 1, 7, 14, 21, 28, 35 for recent memory group and days 1, 7, 14, 21, 28, 35, 42, 49 for remote memory group
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Open field test (OFT)
The OFT is often used to assess exploration in a novel
environment and offers a preliminary screen for anxiety-
related behavior in rats [19]. Before the actual testing, ani-
mals were habituated to the behavioral testing room for
1–2 h sessions on 2 consecutive days. During a 5-min test-
ing, rats were placed individually in the center of a 40 ×
40 cm square drawn in the middle of a black square arena
(80 × 80 × 40 cm) and then allowed to explore the field
freely. The apparatus was cleaned between rats using 70 %
ethanol. Spontaneous exploration behavior in the OFT
were observed and recorded by ANY-maze (Stoelting Co.,
Wood Dale, IL, US), as indicated by total horizontal dis-
tance traveled (m), number of rearings (times), time spent
(s) and number of entries (times) in the center and periph-
eral areas, and freezing time (s).
Elevated plus-maze (EPM)
The EPM is a popular behavioral test for anxiety-like
behavior and is thought to result from natural aversion of
rats to explore elevated and open areas [20]. The appar-
atus was made of brown acrylic plastic with two sets of
opposing arms (open arms: 50 × 10 cm; closed arms: 50 ×
10 × 40 cm), 50 cm from the ground. Rats were placed
individually in an open field for 5 min and then allowed to
start exploring the maze freely from the junction of the
two sets of arms (10 × 10 cm) facing one open arm in a 5-
min test. The maze was cleaned between rats using 70 %
ethanol. Time spent in each arm was recorded using the
ANY-maze with entries being defined as 85 % of the area
of the animal being present in the area entered. Time
spent in open arms, especially the percentage of open arm
time versus closed arm time was evaluated to assess
anxiety.
Morris water maze (MWM)
The MWM was used to assess and compare spatial
learning and memory in cisplatin-treated and control
rats as described previously [26, 67]. Experiments were
performed in a black circular tank (a diameter of 150 cm
with 60 cm depth), which was filled with the opaque
water (22–24 °C) by adding black nontoxic paint. A
circular platform (diameter of 10 cm and 25 cm high)
submerged 2.0 cm below water level in the center of one
of the four quadrants (target quadrant). Behavioral data
of the animal in the water maze were acquired using the
ANY-maze by a digital video camera located above the
center of the tank.
Four consecutive days of probe trainings were per-
formed to assess special learning. Rats were released from
4 randomized release points facing the tank wall to learn
to locate a hidden platform in 60 s using visual orientation
cues on the walls of the tank and on the curtains around
the tank. Rats either found the platform by themselves or
were guided by the experimenter, and remained on the
platform for 10 s. Four trials were conducted each day
with intervals of 30 min between each. Twenty-four hours
or thirty days after the last training session, a single probe
test was performed to assess recent or remote spatial
memory, respectively. The hidden platform was removed
to assess memory retention for the submerged platform
location and rats were released from the farthest position
of original platform and allowed to search the target quad-
rant that previously contained the escape platform. Swim
paths for all trails were recorded and latency to reach plat-
form (sec), distance traveled (m), swimming speed (m/s),
and the amount of time spent in the target quadrant (% of
total time) were calculated to assess spatial recent or
remote memory acquisition and retention/retrieval.
Rat Iowa gambling task (RGT)
The rat Iowa gambling task was used to detect decision-
making. The rats made choices from options associated
with different amounts of reward (food pellets) but also
different amounts and likelihoods of penalties (time-
outs) [18]. The training and test procedures for the rat
were identical to the ones previously described by Riva-
lan et al. [49].
The task was performed in four polyvalent conditioning
boxes (28 × 30 × 34 cm) adapted from five-choice serial
reaction time chambers (Imetronic, Pessac, France). In
each box, there were 4 nose-poke holes illuminated with
white LED on the front curved wall, a food dispenser pro-
viding food pellets (45 mg, TestDiet, USA) at the back wall
and a transparent central opening partition (7 × 7 cm) div-
iding the box into two chambers at the middle. Infra-red
detectors were equipped in holes to detect the nose poke
and connected to the food dispenser.
Prior to the actual training, food was restricted over a 3-
day period following a 1-day fasting period. Simultan-
eously, 50 reward pellets per rat were put inside the cage
every day to make sure the rats became habituated to their
taste. During the training phase, daily food was restricted
for each rat to about 5 g of food per 100 g body weight
and rats usually took 5–7 days to make the association be-
tween nose-pokes in illuminated holes and food rewards
in the food dispenser. In order to guarantee that the selec-
tion of the nose poke was a conscious choice, the rats
were trained to associate a single nose-poke with one food
pellet delivery according to a criterion of at least 100 pel-
lets obtained within a 30-min session, followed by two
consecutive nose-pokes with one food pellet delivery with
the same criterion. Two final 5-min training sessions were
conducted to habituate the rats with the quantity of pellets
that could be obtained during the test. The first session
was set by two nose-pokes with two pellets at a time
(maximum 30 pellets) after making a choice and the other
with one pellet (maximum 15 pellets).
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The test procedure was performed the following day
and lasted 60 min or was cut off by 250 pellets obtain-
ment. Rats were free to make choices among the four
holes (A-D) as during the training phase; however, dif-
ferent choices were associated with different outcomes
set as follows: choices A or B related to two pellets each
time as immediate reward, but had separately 1/2 prob-
ability to trigger a long penalty time-out (222 s) or 1/4
probability for a very long penalty time-out (444 s), dur-
ing which period no pellet can be obtained; choices C or
D associated to smaller immediate reward (one pellets
each time), but also smaller penalty (1/4 chance for 12 s
time-out, or 1/2 chance for 6 s time-out). Although the
immediate reward of choice A and B was twofold that of
choice C and D, in the long run the choice C or D would
allow for the rats to obtain more food pellets compared
to choice A or B. Thus the choices C and D were advan-
tageous choices, while the choices A and B were disad-
vantageous choices. The percentage of advantageous
choices (number of nose-pokes (C + D) / number of
nose-pokes (A + B + C +D) * 100 %) was used as a criter-
ion to distinguish the good (>70 % preference of advan-
tageous choices during the last 20 min of RGT test),
undecided (30 % - 70 % preference) and poor (<30 %
preference) decision-makers. Among the good decision
makers, delayed-good decision-making was determined
when the percentage of advantageous choices was below
70 % at 30 min and above 70 % in the last 20 min.
Electrophysiological recordings
The electrophysiological recordings in both the control
and cisplatin-treated rats were performed after the series
of behavioral tests.
Evoked local field potential (LFP) recording
LFP in the anterior cingulate cortex (ACC) elicited by the
electrical stimulation of the basolateral amygdala (BLA) was
used as a quantitative measure of synaptic potency in BLA-
ACC pathway. Eleven male Sprague–Dawley rats (5 control
and 6 cisplatin-treated rats) were anesthetized (with 1.5 g/kg
urethane, i.p.) and placed in a stereotaxic frame with body
temperature maintained at 36.5 ± 0.5 °C. A glass recording
microelectrode filled with 2.0 M NaCl was slowly lowered
into the ACC (AP 2.0 - 3.8 mm, ML 0.5 - 1.0 mm, depth
1.5 - 3.5 mm). A bipolar tungsten electrode was placed in
the ipsilateral BLA (AP −3.0 to −3.3 mm, ML 4.8 - 5.3 mm,
depth 6.7 - 7.5 mm). To evaluate synaptic potency test stim-
uli (500 μA, square wave pulse, duration: 0.2 ms) were deliv-
ered at 0.033 Hz. After responses stabilized, variations in the
stimulus current (from 50–1000 μA, increasing 50 μA inter-
vals) were delivered in order to generate input–output
curves (I/O). The details of the procedure were similar to
those of previous publications [33, 68].
Long-term potentiation (LTP) induction
To examine the synaptic plasticity, LTP was induced by
applying theta burst stimulation (TBS, three sets of 10
trains with 10 s intervals; each train consisted of 10
bursts at 5 Hz containing 5 pulses at 100 Hz) to the
BLA. The test stimulate intensity was chosen to evoke
50 % of the maximum amplitude of evoked LFP. Details
of the procedure have been described previously [33].
Multiple electrodes recording
In brief, rats were anesthetized and placed in a
stereotaxic frame. Two small holes (1–2 mm wide) were
drilled above the BLA and ACC to insert 16-channel
silicon-based electrodes (Plexon, Dallas, TX). The silver
grounding wires from the electrodes were wrapped
around the mounting screws. Electrodes were slowly
advanced using a micropositioner until clear neuronal
action potentials in most recording channels were ob-
served on-line (OmniPlex® D system, Plexon, Dallas,
TX). LFPs and spike firings were recorded with a 64-
channel electrophysiological data acquisition system.
LFPs were amplified (×20,000), band-pass filtered (0.05 -
200 Hz, 4-pole Bessel) and sampled at 1 kHz. Spikes
were filtered (0.3 - 5 kHz, 4-pole Bessel) and sampled at
40 kHz. Signals from the BLA and ACC were recorded
simultaneously during spontaneous activity and visceral
stimulation (colorectal distention, CRD, 60 mmHg) [33].
Histological identification
After completion of the electrophysiological recordings,
a DC current (100–500 μA) was passed between the
recording electrodes and ground to lesion the brain. The
rats were perfused with saline followed by 4 % parafor-
maldehyde and then the brains were sliced at 50 μm and
stained with Cresyl violet. Drawings were made of sec-
tions showing electrode tracks related to the structure of
the ACC and BLA. A standard rat atlas was used as ref-




Data from the behavioral tests were analyzed by ANY-
maze, POLY File (Imetronic, Pessac, France), SPSS (IBM
SPSS Statistics 20) and GraphPad (Prism 5.0). Data were
compared using student’s unpaired t-test and one-way
and two-way analysis of variance (ANOVA) followed by
the Bonferroni post hoc test. Comparisons of propor-
tions of individuals in the gambling task were conducted
using the non-parametric Mann–Whitney test. The
neural data were processed off-line using NeuroExplorer
5 (Plexon, Dallas, TX) and exported to custom written
MATLAB (MathWorks, Natick, MA) programs for add-
itional analysis. Data sets were compared by one-way
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repeated-measures ANOVA followed by multiple com-
parisons of Bonferroni’s test using Prism 5.0 (GraphPad,
La Jolla, CA). Results were expressed as mean ± SE. P <
0.05 was considered statistically significant.
Spike sorting
The single-unit spike sorting was performed with Off-
Line Spike Sorter V3 software (OFSS, Plexon Inc., Dal-
las, TX) using combined manual and automatic sorting
techniques. Spikes were identified when 3 SDs higher
than the noise amplitude. All waveforms recorded from
each channel were isolated as distinct clusters in 3D
space based on the characteristics of spike waveforms
using principal component analysis (PCA). Automatic
techniques were used to generate separation of wave-
forms into individual clusters. Manual checking was
performed to ensure that the spike waveforms were
consistent and cluster boundaries were clearly sepa-
rated. All isolated single-units exhibited recognizable
refractory periods (≥1 ms) in the inter-spike interval
(ISI) histograms [70].
Spectral analysis
Oscillatory brain activity in the theta (4–10 Hz) frequency
range is believed to temporally linked single neuron into
assemblies cooperatively facilitate synaptic plasticity [40],
and plays a role in many different cognitive functions,
including memory and decision making [45]. To clarify
alterations in the theta power spectra following cisplatin
treatment, we calculated the ACC theta power, peak fre-
quency of the theta oscillations, as well as the theta ratio
(theta/(theta + delta). In order to achieve this, the raw
ACC LFPs were filtered between 1 and 100 Hz using non-
causal zero-phase-shift filter (fourth-order Butterworth).
The power spectral densities (PSD) were characterized
using multi-taper estimates with 7 tapers and 213 fre-
quency bins (NeuroExplorer 5, Plexon, Dallas, TX). The
overlapping percentage of each window is 50 %. The
power spectra were normalized so that the sum of all the
spectrum values equals the mean squared value of the sig-
nal. The PSD curve was smoothed with a Gaussian filter
(15 bins running average), with the band power being
defined as the area under the curve (AUC) of the corre-
sponding frequency domain. The power from each animal
was averaged over the 16 channels and to compute the
theta/delta ratio, the AUC of the theta band power to the
theta plus delta band (1–10 Hz) was calculated. To expose
the time-frequency features of the theta oscillations in
both BLA and ACC, the time-varying power spectra were
calculated by FFT with Hann window function using
NeuroExplorer 5. The spectrum units were normalized by
raw PSD, so that the sum of all the spectrum values equals
to the mean squared value of the signal.
The phase-locking of single neuron activity to the theta
oscillations of local field potential
To investigate the angular distributions of spikes in rela-
tion to the theta oscillation, and clarify the significance
of phase-locking of spikes with the theta oscillation, the
phase distribution and Rayleigh test were performed
using in house MATLAB scripts modified based on the
study in [17]. To ensure the validity of the statistical re-
sults, only neurons that had at least 50 spikes were used
for phase-locking estimation. Before performing the ana-
lysis, 22 different frequencies ranging from 1.6 to 64 Hz
were selected, such that, f = 2x with x = {6/8, 8/8, 10/8,
12/8, …, 48/8}. The LFP was then convolved with a
series of Morlet wavelets centered about each of the
selected frequencies and each with a length of 4 cycles.
The result of these wavelet transforms, is a matrix of
vectors whose absolute values (or length) and arguments
(or angles) represent the amplitude and phase, respect-
ively, of the LFP at frequency f and time t. At each of
the selected frequencies, the phase angle of each spike
was estimated from the inverse tangent of the real and
imaginary components of the wavelet transform. The
circular mean of the spike phases was calculated by
taking the weighted sum of the cosine and sine of the
angles. The mean angle was then the angle of the results
and the mean vector length (R) the absolute value over
the number of spikes. To check for phase-locking, the
Rayleigh test was used to compare against uniformity by
calculating the test statistic and a p value. A neuron was
considered phase locked in theta range if the P value is
below the threshold of 0.0023 which is 0.05 Bonferroni
corrected for multiple comparisons (0.05/22, twenty-two
frequencies were tested) [17].
Synchronized theta oscillations between BLA and ACC by
cross-correlation analyses
The synchronized theta activities between the BLA LFPθ
and ACC LFPθ were evaluated by cross-correlograms using
NeuroExplorer 5 software. We aligned the 2 LFPθs and
chose the BLA LFPθ as reference. The Pearson correlation
values were calculated with a lag time ranging from −0.5 to
0.5 s with small bins (2 ms). The cross-correlation curves
were smoothed with a Gaussian filter (5 bins running aver-
age). We averaged the cross-correlograms from valid elec-
trode channels in the BLA and ACC and took the second
positive peak as a quantitative measure because it locates at
about 0.2 s lag time which represents theta activity at about
5 Hz [71].
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